Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis-Reference-Cited by-同舟云学术

Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis

Published:2013-07-27 Issue:1 Volume:163 Page:40-46
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Pozzi Samantha¹,Marcheselli Luigi,Bari Alessia¹,Liardo Eliana V.¹,Marcheselli Raffaella¹,Luminari Stefano²,Quaresima Micol²,Cirilli Claudia³,Ferri Paola⁴,Federico Massimo,Sacchi Stefano¹

Affiliation:

1. Programme of Innovative Therapy in Oncology and Haematology; Department of Diagnostic, Clinical and Public Health Medicine; University of Modena and Reggio Emilia; Modena; Italy

2. Medical Oncology; Department of Diagnostic, Clinical and Public Health Medicine; University of Modena and Reggio Emilia; Modena; Italy

3. Modena Cancer Registry; Modena; Italy

4. Nursing School; Department of Diagnostic; Clinical and Public Health Medicine; University of Modena and Reggio Emilia; Modena; Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12465/fullpdf

Reference15 articles.

1. Survival outcomes in elderly patients with plasma cell myeloma: the three-decade Eastern Cooperative Oncology Group (ECOG) experience;Campagnaro;Journal of Clinical Oncology,2011

2. Regression models and life tables;Cox;Journal of the Royal Statistical Society. Series B (Methodological),1972

3. Regression models for relative survival;Dickman;Statistics in Medicine,2004

4. Ederer , F. Heise , H. 1959 Instructions to IBM 650 programmers in processing survival computations National Cancer Institute Bethesda, MD, USA

5. Cancer statistics, 2000;Greenlee;CA: A Cancer Journal for Clinician,2000

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic frailty-based determinants of long-term mortality in older patients with newly diagnosed multiple myeloma;2024-08-20

2. Progression-Free Survival Efficacy in Refractory/Relapsed Multiple Myeloma among Elderly Patients: A Systematic Review;Life;2023-11-27

3. Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future;Cancers;2023-07-20

4. Large-scale real-life analysis of survival and usage of therapies in multiple myeloma;Journal of Hematology & Oncology;2023-07-19

5. Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma;Cancers;2023-03-02